Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 86, 42-49
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- Blockade of Nicotine Reward and Reinstatement by Activation of Alpha-Type Peroxisome Proliferator-Activated ReceptorsBiological Psychiatry, 2011
- Reward, dopamine and the control of food intake: implications for obesityTrends in Cognitive Sciences, 2011
- Peroxisome Proliferator-Activated Receptors-Alpha Modulate Dopamine Cell Activity Through Nicotinic ReceptorsBiological Psychiatry, 2010
- Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addictionTrends in Neurosciences, 2009
- Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in PrimatesBiological Psychiatry, 2008
- Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified miceBehavioural Pharmacology, 2008
- Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ miceNeuropharmacology, 2008
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolChemistry & Biology, 2007
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptorsBritish Journal of Pharmacology, 2007
- Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB1 and TRPV1 receptorsExperimental Neurology, 2007